Antiviral activity of human beta-defensin 3 against vaccinia virus
about
Antiviral mechanisms of human defensinsRecent insights into atopic dermatitis and implications for management of infectious complications.Perspectives for clinical use of engineered human host defense antimicrobial peptidesCharacterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus.Antibacterial and antiviral roles of a fish β-defensin expressed both in pituitary and testis.Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes.Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell statusTherapeutic and prophylactic drugs to treat orthopoxvirus infectionsCationic host defence peptides: potential as antiviral therapeuticsUpregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcomaIL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.Defensins in viral infections.Atopic dermatitis - from new pathophysiologic insights to individualized therapy.Host defense peptide-derived privileged scaffolds for anti-infective drug discovery.An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
P2860
Q27023010-4F21B894-CC4E-4A1A-96E7-86F0C49F736CQ33621496-18C47CA0-7A7B-4E9A-A001-F4285FC095EBQ33700825-3463620C-0F27-4356-AEAD-BC42672C1AF2Q33725157-E151BAA8-BE3C-42FF-8DEF-443540E8AB30Q33781218-ADFC9732-B06E-4E37-A61C-A2E7BFB1C363Q34714569-70BCE34B-53E5-46A8-B619-9B06E080DC97Q35795457-AA7539D4-407D-47E9-A794-3A7651A2B2D8Q37009973-C02DD7F1-C917-443E-BC99-4567CF70C8F9Q37177085-C4A6350D-CE8D-4EC1-9FB6-1C4BB8D490F6Q37195726-928911D1-641B-45C7-B0C6-7BDD50FD4F3BQ37203388-4D2DB2FF-9A27-4C61-8199-A50C078A2ABFQ37726739-84047CB4-95C7-4F89-BDC5-70A15BC5614FQ37848872-9588E7C2-EC86-45E1-B0F0-924DC771CDF6Q38721745-2F6CF1DB-4B28-4021-BB31-C36B5EDE405FQ41033958-68EAB232-82A3-4046-9BCC-A07231B00FD5Q42708917-A845E305-120D-495C-986B-029DACDACB08
P2860
Antiviral activity of human beta-defensin 3 against vaccinia virus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral activity of human beta-defensin 3 against vaccinia virus
@en
Antiviral activity of human beta-defensin 3 against vaccinia virus.
@nl
type
label
Antiviral activity of human beta-defensin 3 against vaccinia virus
@en
Antiviral activity of human beta-defensin 3 against vaccinia virus.
@nl
prefLabel
Antiviral activity of human beta-defensin 3 against vaccinia virus
@en
Antiviral activity of human beta-defensin 3 against vaccinia virus.
@nl
P2093
P2860
P1476
Antiviral activity of human beta-defensin 3 against vaccinia virus
@en
P2093
Donald Y M Leung
Joanne E Streib
Michael D Howell
P2860
P304
P356
10.1016/J.JACI.2007.01.044
P407
P577
2007-03-13T00:00:00Z